Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 16, 2003BJU International

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

ADAnna J. Duffield‐LillicoMemorial Sloan Kettering Cancer CenterBDB.L. DalkinVirginia Mason Medical CenterMRMarvin ReidUniversity of the West Indies

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Duffield‐Lillico et al. (2003) studied this question.

synapsesocial.com/papers/6a80f0e7d7cc36764365f033https://doi.org/10.1046/j.1464-410x.2003.04167.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin1996 · 1,935 citations
  2. 2Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer1998 · 347 citations
  3. 3Staging prostate cancer2000 · 59 citations
  4. 4SERUM LEVELS OF SELENIUM AND RETINOL AND THE SUBSEQUENT RISK OF CANCER1988 · 156 citations